| Mepolizumab for eosinophilic granulomatosis with polyangiitis: a European multicenter observational study A Bettiol, ML Urban, L Dagna, V Cottin, F Franceschini, S Del Giacco, ... Arthritis & Rheumatology 74 (2), 295-306, 2022 | 96 | 2022 |
| Practical considerations for spirometry during the COVID-19 outbreak: Literature review and insights C Crimi, P Impellizzeri, R Campisi, S Nolasco, A Spanevello, N Crimi Pulmonology 27 (5), 438-447, 2021 | 68 | 2021 |
| Real‐life evaluation of mepolizumab efficacy in patients with severe eosinophilic asthma, according to atopic trait and allergic phenotype C Pelaia, C Crimi, G Pelaia, S Nolasco, R Campisi, E Heffler, G Valenti, ... Clinical & Experimental Allergy 50 (7), 780-788, 2020 | 59 | 2020 |
| First case of monkeypox virus, SARS-CoV-2 and HIV co-infection S Nolasco, F Vitale, A Geremia, F Tramuto, CM Maida, A Sciuto, C Coco, ... Journal of Infection 86 (1), e21-e23, 2023 | 52 | 2023 |
| High-flow nasal oxygen versus conventional oxygen therapy in patients with COVID-19 pneumonia and mild hypoxaemia: a randomised controlled trial C Crimi, A Noto, F Madotto, M Ippolito, S Nolasco, R Campisi, S De Vuono, ... Thorax 78 (4), 354-361, 2023 | 51 | 2023 |
| Benralizumab effectiveness in severe eosinophilic asthma with and without chronic rhinosinusitis with nasal polyps: a real-world multicenter study S Nolasco, C Crimi, C Pelaia, A Benfante, MF Caiaffa, C Calabrese, ... The Journal of Allergy and Clinical Immunology: In Practice 9 (12), 4371 …, 2021 | 47 | 2021 |
| Therapeutic effects of benralizumab assessed in patients with severe eosinophilic asthma: real-life evaluation correlated with allergic and non-allergic phenotype expression C Pelaia, C Crimi, A Benfante, MF Caiaffa, C Calabrese, GE Carpagnano, ... Journal of Asthma and Allergy, 163-173, 2021 | 46 | 2021 |
| Real-life effectiveness of mepolizumab in patients with severe refractory eosinophilic asthma and multiple comorbidities C Crimi, R Campisi, G Cacopardo, R Intravaia, S Nolasco, M Porto, ... World Allergy Organization Journal 13 (9), 100462, 2020 | 43 | 2020 |
| Mepolizumab effectiveness in patients with severe eosinophilic asthma and co-presence of bronchiectasis: a real-world retrospective pilot study C Crimi, R Campisi, S Nolasco, G Cacopardo, R Intravaia, M Porto, ... Respiratory Medicine, 106491, 2021 | 39 | 2021 |
| Real-world experience with dupilumab in severe asthma: one-year data from an Italian named patient program R Campisi, C Crimi, S Nolasco, B Beghè, L Antonicelli, G Guarnieri, ... Journal of asthma and allergy, 575-583, 2021 | 36 | 2021 |
| Type 2-high severe asthma with and without bronchiectasis: a prospective observational multicentre study C Crimi, R Campisi, S Nolasco, S Ferri, G Cacopardo, P Impellizzeri, ... Journal of Asthma and Allergy, 1441-1452, 2021 | 24 | 2021 |
| Comparability of asthma control test scores between self and physician-administered test C Crimi, R Campisi, A Noto, S Genco, G Cacopardo, S Nolasco, N Crimi Respiratory Medicine 170, 106015, 2020 | 22 | 2020 |
| Effectiveness of benralizumab in severe eosinophilic asthma: Distinct sub‐phenotypes of response identified by cluster analysis D Di Bona, C Crimi, AM D’Uggento, A Benfante, MF Caiaffa, C Calabrese, ... Clinical & Experimental Allergy 52 (2), 312-323, 2022 | 21 | 2022 |
| Real-life effects of dupilumab in patients with severe type 2 asthma, according to atopic trait and presence of chronic rhinosinusitis with nasal polyps C Pelaia, A Benfante, MT Busceti, MF Caiaffa, R Campisi, ... Frontiers in Immunology 14, 1121237, 2023 | 19 | 2023 |
| Switch from omalizumab to benralizumab in allergic patients with severe eosinophilic asthma: a real-life experience from southern Italy C Pelaia, C Crimi, S Nolasco, GE Carpagnano, R Brancaccio, ... Biomedicines 9 (12), 1822, 2021 | 18 | 2021 |
| High-flow nasal cannula oxygen therapy: physiological mechanisms and clinical applications in children S Nolasco, S Manti, S Leonardi, C Vancheri, L Spicuzza Frontiers in Medicine 9, 920549, 2022 | 14 | 2022 |
| Case Report: Acute effect of benralizumab on asthma exacerbation without concomitant corticosteroid use S Nolasco, R Campisi, R Intravaia, M Porto, C Pelaia, N Crimi, C Crimi F1000Research 9, 2020 | 13 | 2020 |
| Long-term domiciliary high-flow nasal therapy in patients with bronchiectasis: a preliminary retrospective observational case-control study C Crimi, S Nolasco, R Campisi, M Nigro, P Impellizzeri, A Cortegiani, ... Journal of Clinical Medicine 11 (24), 7323, 2022 | 10 | 2022 |
| Switching biological therapies in severe asthma G Scioscia, S Nolasco, R Campisi, CMI Quarato, C Caruso, C Pelaia, ... International Journal of Molecular Sciences 24 (11), 9563, 2023 | 9 | 2023 |
| Benralizumab effectiveness in severe eosinophilic asthma with co-presence of bronchiectasis: a real-world multicentre observational study R Campisi, S Nolasco, C Pelaia, P Impellizzeri, M D’Amato, A Portacci, ... Journal of Clinical Medicine 12 (12), 3953, 2023 | 8 | 2023 |
Claudia CrimiPoliclinico "G. Rodolico"- San MarcoEmail verificata su unict.it
